Transgender In Transition

Recruiting now

Conditions studied: Gender Incongruence

In brief

Prospective trial in gender dysphoric patients who undergo gender-affirming hormone therapy, aiming to investigate psychological, biological and behavioural consequences of hormonal therapy.

Key facts

Study ID

NCT04028219

Run by

Universitätsklinikum Hamburg-Eppendorf

People needed

750

Starts

2019-05-15

Expected to finish

2034-05-15

Last updated by the study team

2022-11-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosis of gender incongruence (ICD-11) or gender dysphoria (DSM-5)
• written informed consent following adequate oral and written Information
• before gender-affirming hormonal treatment

You may not qualify if…

• pregnancy or breast-feeding

Where it is running

• University Medical Center Hamburg-Eppendorf — Hamburg, Germany (enrolling)
• Universitätsklinikum Frankfurt — Frankfurt am Main, Hesse, Germany
• Medical Center of the Ludwig-Maximilians-University of Munich — Munich, Germany
• Universitätsspital Basel — Basel, Switzerland
• UniversitätsSpital Zürich — Zurich, Switzerland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.